Insights

Innovative Technology Platform AxoSim's microBrain organoid platform offers highly consistent and physiologically relevant human CNS models, making it attractive for pharmaceutical companies seeking advanced neurotoxicity testing, neuromodulation research, and CNS drug discovery solutions.

Expanding Market Presence Recent leadership hires and increased investments in facility expansion highlight AxoSim's growth trajectory, indicating a rising demand for its organoid technology and potential for entering new markets within neurobiological research and therapeutics.

Strategic Asset Acquisition The acquisition of Vyant Bio's StemoniX assets positions AxoSim to broaden its product offerings and enhance its capabilities, providing opportunities to cross-sell to existing clients and attract new customers interested in CNS screening platforms.

Market Position & Competitors With revenue estimates between 1M and 10M and comparable companies like BrainWorks and NeuroFlow, AxoSim has the opportunity to differentiate itself through its high-throughput and physiologically accurate 3D organoid technology to capture a larger share of the neurodiscovery market.

Customer and Partner Opportunities AxoSim’s focus on neurotoxicology and drug screening aligns well with pharmaceutical and biotech sectors, creating potential sales opportunities for partnerships, custom testing services, and collaborations aimed at accelerating CNS therapeutics development.

Similar companies to StemoniX, acquired by AxoSim

StemoniX, acquired by AxoSim Tech Stack

StemoniX, acquired by AxoSim uses 8 technology products and services including Webpack, JSON-LD, TweenMax, and more. Explore StemoniX, acquired by AxoSim's tech stack below.

Webpack
Development
JSON-LD
Javascript Frameworks
TweenMax
Javascript Frameworks
jQuery
Javascript Libraries
Modernizr
Javascript Libraries
Flywheel
Platform As A Service
PHP
Programming Languages
ZURB Foundation
UI Frameworks

Media & News

StemoniX, acquired by AxoSim's Email Address Formats

StemoniX, acquired by AxoSim uses at least 2 format(s):

StemoniX, acquired by AxoSim Email Formats	Example	Percentage
First.Last@stemonix.com	John.Doe@stemonix.com	90%
FirLast@stemonix.com	JohDoe@stemonix.com	7%
First_L@stemonix.com	John_D@stemonix.com	3%
First.Last@axosim.com	John.Doe@axosim.com	91%
First.M.Last@axosim.com	John.M.Doe@axosim.com	7%
Fir.Last@axosim.com	Joh.Doe@axosim.com	2%

Frequently Asked Questions

Where is StemoniX, acquired by AxoSim's headquarters located?

StemoniX, acquired by AxoSim's main headquarters is located at 13300 67th Avenue North Maple Grove, Minnesota 55311 United States. The company has employees across 1 continents, including North America.

What is StemoniX, acquired by AxoSim's phone number?

You can contact StemoniX, acquired by AxoSim's main corporate office by phone at

+1-612-804-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is StemoniX, acquired by AxoSim's official website and social media links?

StemoniX, acquired by AxoSim's official website is axosim.com and has social profiles on LinkedIn Crunchbase.

What is StemoniX, acquired by AxoSim's SIC code NAICS code?

StemoniX, acquired by AxoSim's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does StemoniX, acquired by AxoSim have currently?

As of June 2026, StemoniX, acquired by AxoSim has approximately 3 employees across 1 continents, including North America. Key team members include Information Technology Manager: D. M.Project Manager: M. W.Administrative Assistant: B. U.. Explore StemoniX, acquired by AxoSim's employee directory with LeadIQ.

What industry does StemoniX, acquired by AxoSim belong to?

StemoniX, acquired by AxoSim operates in the Biotechnology Research industry.

What technology does StemoniX, acquired by AxoSim use?

StemoniX, acquired by AxoSim's tech stack includes WebpackJSON-LDTweenMaxjQueryModernizrFlywheelPHPZURB Foundation.

What is StemoniX, acquired by AxoSim's email format?

StemoniX, acquired by AxoSim's email format typically follows the pattern of First.Last@stemonix.com. Find more StemoniX, acquired by AxoSim email formats with LeadIQ.

When was StemoniX, acquired by AxoSim founded?

StemoniX, acquired by AxoSim was founded in 2014.

StemoniX, acquired by AxoSim

Q: How many employees does StemoniX, acquired by AxoSim have currently?

StemoniX, acquired by AxoSim has approximately 3 employees.

Q: What technology does StemoniX, acquired by AxoSim use?

StemoniX, acquired by AxoSim's tech stack includes ZURB Foundation, Indeed, oEmbed, X-Content-Type-Options, Microsoft.

Q: What is StemoniX, acquired by AxoSim's NAICS code?

StemoniX, acquired by AxoSim's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchMinnesota, United States2-10 Employees

AxoSim, Inc. acquired the microBrain™-associated assets of Vyant Bio’s StemoniX subsidiary in October 2023.

The microBrain™ technology provides a physiologically relevant human iPSC-derived screening platform for CNS drug discovery and toxicity testing. The organoid platform replicates important human CNS biology, containing cortical neurons and astrocytes that self-organize and form functional networks in 3D. The hallmark of the microBrain™ organoids is their remarkably consistent performance, making them ideal for high-throughput neurotoxicology, neuromodulation, and drug discovery investigations.

For more information about microBrain™ contact sales@axosim.com

Company Overview

Headquarters: 13300 67th Avenue North Maple Grove, Minnesota 55311 United States
Phone number: +1-612-804-****
Website: axosim.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2014
Employees: 2-10

Media & News

Funding & Financials

$1M$10M
StemoniX, acquired by AxoSim's revenue is estimated to be in the range of $1M$10M

Funding & Financials

$1M$10M
StemoniX, acquired by AxoSim's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to StemoniX, acquired by AxoSim

KERNEL

BrainWorks

Muse

EMOTIV

NeuroFlow

deCervo

Halo Neuroscience

StemoniX, acquired by AxoSim Tech Stack

Media & News

AxoSim, Inc. hired Stuart Gibb as Vice President of Sales and Marketing on Sep 17th '24.

AxoSim, Inc. hires Saleh as CEO.

AxoSim, Inc. hired David Weiner as co-chairs of the board of directors on Feb 28th '24.

AxoSim, Inc. hired Dale Pfost as board co-chairs on Feb 28th '24.

AxoSim, Inc. invests into assets: vyant bio's stemonix assets.

Vyantbio sold assets to AxoSim, Inc. in the amount of $2.25M on Jul 24th '23.

AxoSim, Inc. increases headcount by 75.

StemoniX, acquired by AxoSim's Email Address Formats

Frequently Asked Questions

Where is StemoniX, acquired by AxoSim's headquarters located?

What is StemoniX, acquired by AxoSim's phone number?

What is StemoniX, acquired by AxoSim's official website and social media links?

What is StemoniX, acquired by AxoSim's SIC code NAICS code?

How many employees does StemoniX, acquired by AxoSim have currently?

What industry does StemoniX, acquired by AxoSim belong to?

What technology does StemoniX, acquired by AxoSim use?

What is StemoniX, acquired by AxoSim's email format?

When was StemoniX, acquired by AxoSim founded?

StemoniX, acquired by AxoSim

Company Overview

Media & News

AxoSim, Inc. hired Stuart Gibb as Vice President of Sales and Marketing on Sep 17th '24.

AxoSim, Inc. hires Saleh as CEO.

AxoSim, Inc. hired David Weiner as co-chairs of the board of directors on Feb 28th '24.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?